1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rise In Aging Population
3.2.2. Rapid Growth Of The Aesthetic Industry
3.2.3. Medical Tourism In Developing Markets
3.2.4. Preference For Minimally Invasive And Non-Invasive Procedures Over Invasive Procedures
3.2.5. Surge In Disposable Income
3.3. Key Restraints
3.3.1. High Rate Of Aesthetic Usages
3.3.2. Difficulties Related To Cosmetic Treatment
3.3.3. High Cost Of Implantable Medical Devices
3.3.4. Safety Concerns Related To Breast Implant
3.3.5. Availability Of Alternative Treatments
3.3.6. Lack Of Reimbursement

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Market Trends
4.3. Value Chain Analysis
4.4. Regulatory Framework
4.5. Opportunity Matrix
4.6. Vendor Landscape
4.7. Key Investment Insights

5. Market By Type
5.1. Surgical
5.1.1. Breast Augmentation
5.1.2. Liposuction
5.1.3. Eyelid Surgery
5.1.4. Tummy Tuck
5.1.5. Breast Lift
5.1.6. Other Surgical Types
5.2. Non-Surgical
5.2.1. Botulinum Toxin
5.2.2. Dermal Fillers
5.2.3. Laser Hair Removal
5.2.4. Chemical Peel
5.2.5. Microdermabrasion
5.2.6. Photo-Rejuvenation
5.2.7. Other Non-Surgical Types

6. Geographical Analysis
6.1. Europe
6.1.1. Germany
6.1.2. The United Kingdom
6.1.3. France
6.1.4. Italy
6.1.5. Russia
6.1.6. Belgium
6.1.7. Poland
6.1.8. Rest Of Europe

7. Company Profiles
7.1. Allergan Plc
7.2. Alma Lasers Ltd (Acquired By Fosun Pharma)
7.3. Bausch Health Companies Inc (Formerly Valeant Pharmaceuticals)
7.4. Candela Corp (Formerly Syneron Medical Ltd)
7.5. Cutera Inc
7.6. Cynosure (Acquired By Clayton, Dubilier & Rice)
7.7. Depuy Synthes Companies (Acquired By Johnson & Johnson)
7.8. Galderma (Acquired By Eqt)
7.9. Ipsen S.A.
7.10. Johnson & Johnson
7.11. Lumenis Ltd
7.12. Merz Pharma
7.13. Sientra Inc
7.14. Sinclair Pharma Plc